ABVC BioPharma, Inc. (ABVC)
1.00
+0.02
(+2.04%)
USD |
NASDAQ |
Oct 09, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma EPS Diluted (Quarterly) : -0.0283 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0283 |
| March 31, 2026 | -0.0613 |
| December 31, 2025 | -0.1104 |
| September 30, 2025 | -0.0878 |
| June 30, 2025 | -0.1298 |
| March 31, 2025 | -0.0563 |
| December 31, 2024 | 0.0165 |
| September 30, 2024 | -0.0318 |
| June 30, 2024 | -0.0832 |
| March 31, 2024 | -0.2911 |
| December 31, 2023 | -0.3918 |
| September 30, 2023 | -0.8181 |
| June 30, 2023 | -0.6841 |
| March 31, 2023 | -0.5514 |
| December 31, 2022 | -1.481 |
| September 30, 2022 | -1.137 |
| June 30, 2022 | -0.5938 |
| March 31, 2022 | -2.020 |
| September 30, 2021 | -0.672 |
| June 30, 2021 | -0.8073 |
| March 31, 2021 | -0.4621 |
| December 31, 2020 | -2.008 |
| September 30, 2020 | -0.9473 |
| June 30, 2020 | -0.9544 |
| March 31, 2020 | -0.6403 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.5612 |
| September 30, 2019 | -0.6387 |
| June 30, 2019 | -0.32 |
| March 31, 2019 | -0.5292 |
| December 31, 2018 | -3.249 |
| September 30, 2018 | -0.4806 |
| June 30, 2018 | -0.5454 |
| March 31, 2018 | -0.5184 |
| December 31, 2017 | -0.3204 |
| September 30, 2017 | -3.60 |
| June 30, 2017 | -0.18 |
| December 31, 2016 | -0.18 |
| September 30, 2016 | -9.097 |
| June 30, 2016 | -0.252 |
| March 31, 2016 | -5.40 |
| December 31, 2015 | -1.146 |
| September 30, 2015 | -0.0292 |
| June 30, 2015 | -8.596 |
| March 31, 2015 | 5.731 |
| December 31, 2014 | -5.731 |
| September 30, 2014 | -126.07 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
| MiMedx Group, Inc. | -0.1004 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.1689 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8105M |
| Total Expenses (Quarterly) | 0.7369M |
| Enterprise Value | 30.54M |
| Earnings Yield | -28.78% |
| Normalized Earnings Yield | -26.54 |